BridgeMD
New treatment option for Mature B-Cell Neoplasm
Official title Study of SGR-1505 in Mature B-Cell Neoplasms
ClinicalTrials.gov ID: NCT05544019
What this study is testing
What is SGR-1505?
SGR-1505 is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for mature b-cell neoplasm.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The purpose of this study is to evaluate safety and tolerability and to determine the maximum tolerated dose (MTD) or maximum administered dose (MAD) and/or recommended dose (RD) of SGR-1505.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Subject must have a history of histologically or cytologically confirmed mature B-cell malignancy.
- Subject must have measurable or detectable disease according to the applicable disease-specific classification system and meet criteria for...
- Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1.
- Life expectancy ≥ 12 weeks.
You likely can't join if
- The subject is in need of immediate cytoreductive therapy (unless the patient has no remaining treatment choice with potential benefit).
- Subject has previous invasive malignancy in the last 2 years.
- Subject has a known allergy to SGR-1505 or excipients of SGR-1505.
- Subject has symptomatic or active CNS involvement of disease.
- Any other diseases, metabolic dysfunction, physical examination finding, or clinical laboratory finding that would place the participant at increased...
The study team makes the final eligibility decision.
Where it's taking place
- Gilbert, Arizona, United States
- Newark, Delaware, United States
- Pompano Beach, Florida, United States
- Boston, Massachusetts, United States
- Hackensack, New Jersey, United States
- Buffalo, New York, United States
- New York, New York, United States
- The Bronx, New York, United States
- Durham, North Carolina, United States
- Canton, Ohio, United States
- Columbus, Ohio, United States
- Portland, Oregon, United States
- Providence, Rhode Island, United States
- Dallas, Texas, United States
- Seattle, Washington, United States
- Milwaukee, Wisconsin, United States
- Créteil, France
- Villejuif, France
- Alessandria, Italy
- Milan, Italy
+ 13 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Gilbert, Arizona, United States; Newark, Delaware, United States; Pompano Beach, Florida, United States; Boston, Massachusetts, United States; Hackensack, New Jersey, United States; Buffalo, New York, United States and 27 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.